MSCV-Nkx2-1/Puro Citations (3)

Originally described in: Suppression of lung adenocarcinoma progression by Nkx2-1.
Winslow MM, Dayton TL, Verhaak RG, Kim-Kiselak C, Snyder EL, Feldser DM, Hubbard DD, DuPage MJ, Whittaker CA, Hoersch S, Yoon S, Crowley D, Bronson RT, Chiang DY, Meyerson M, Jacks T Nature. 2011 May 5. 473(7345):101-4. PubMed Journal

---

Articles Citing MSCV-Nkx2-1/Puro

Articles
Conversion of human and mouse fibroblasts into lung-like epithelial cells. Wong AP, Shojaie S, Liang Q, Xia S, Di Paola M, Ahmadi S, Bilodeau C, Garner J, Post M, Duchesneau P, Waddell TK, Bear CE, Nagy A, Rossant J. Sci Rep. 2019 Jun 21;9(1):9027. doi: 10.1038/s41598-019-45195-y. PubMed
Mutationally-activated PI3'-kinase-alpha promotes de-differentiation of lung tumors initiated by the BRAF(V600E) oncoprotein kinase. van Veen JE, Scherzer M, Boshuizen J, Chu M, Liu A, Landman A, Green S, Trejo C, McMahon M. Elife. 2019 Aug 27;8. pii: 43668. doi: 10.7554/eLife.43668. PubMed
The kinase PLK1 promotes the development of Kras/Tp53-mutant lung adenocarcinoma through transcriptional activation of the receptor RET. Kong Y, Allison DB, Zhang Q, He D, Li Y, Mao F, Li C, Li Z, Zhang Y, Wang J, Wang C, Brainson CF, Liu X. Sci Signal. 2022 Oct 4;15(754):eabj4009. doi: 10.1126/scisignal.abj4009. Epub 2022 Oct 4. PubMed

If you have published an article using this material, please email us at to have your article added to this page.